Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 1 - Studien 1 bis 8 von insgesamt 8
- Rekrutierung läuftRamucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy - The Phase II/IIIRAMIRIS STUDYMolekulare Marker
- Rekrutierung läuft
A Randomized, Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unresectable Melanoma
IndikationenMolekulare Marker - Rekrutierung läuft
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 directed CART Cell Therapy (PAVO)
Molekulare Marker - Rekrutierung läuftEvaluierung der adjuvanten Therapie beim Dickdarmkrebs im Stadium II nach ctDNA-BestimmungMolekulare Marker
- Rekrutierung läuftLong-Term Follow up Protocol for subjects treated with gene-modified T Cells
- Rekrutierung läuftAn International Clinical Program for the diagnosis and Treatment of children, adolescents and young adults with ependymoma
- Rekrutierung läuftAn International Prospective Study on Clinically Standard-Risk Medulloblastoma in Children Older than 3 to 5 Years with Low-Risk Biological Profile (PNET 5 MB - LR) or Average-Risk Biological Profile (PNET 5 MB - SR)
- Rekrutierung läuftInternational Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma.